Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 2,613 shares at $251.42 ($656K) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Open-market sale of $656k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $247.77 | 26 | $6K | 1.0% |
| 2 | $249.60 | 215 | $54K | 8.2% |
| 3 | $250.68 | 318 | $80K | 12.2% |
| 4 | $250.68 | 318 | $80K | 12.2% |
| 5 | $251.42 | 826 | $208K | 31.7% |
| 6 | $251.42 | 826 |
| $208K |
| 31.7% |
| 7 | $252.27 | 84 | $21K | 3.2% |
| Total | $251.08 avg | 2,613 | $656K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |